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Summary 
Experimental data suggest that negative selection of thymocytes can occur as a result of su- 
praoptimal antigenic stimulation.  It is unknown,  however, whether such mechanisms are at 
work in mature CD8 + T  lymphocytes. Here, we show that CD8 + effector cytotoxic T  lym- 
phocytes (CTL) are susceptible to proliferative inhibition by high dose peptide antigen, leading 
to apoptotic death mediated by TNF-ci release. Such inhibition is not reflected in the cytolytic 
potential of the CTL, since concentrations of antigen that are inhibitory for proliferation pro- 
mote efficient lysis of target cells. Thus, although CTL have committed to the apoptotic path- 
way,  the kinetics of this process are such that  CTL function can occur before death of the 
CTL. The concentration of antigen required for inhibition is a function of the CTL avidity, in 
that concentrations of antigen capable of completely inhibiting high avidity CTL maximally 
stimulate low avidity CTL. Importantly, the inhibition can be detected in both activated and 
resting CTL. Blocking studies demonstrate that the CD8 molecule contributes significantly to 
the inhibitory signal  as the addition of anti-CD8  antibody restores the proliferative response. 
Thus, our data support the model that mature CD8 + CTL can accommodate an activation sig- 
nal of restricted intensity, which, if surpassed,  results in deletion of that cell. 
T 
he induction and maintenance  of tolerance has  been 
shown to significantly limit the potentially deleterious 
responses of self-reactive T  lymphocytes. Although thymic 
education is thought to contribute significantly to the erad- 
ication of self-reactive T  cells (1, 2), the induction of toler- 
ance via peripheral exposure to antigen has been well doc- 
umented (3-9). Deletion and/or inactivation of peripheral, 
antigen-reactive  T  lymphocytes  has  been  observed  in  a 
number of experimental systems, including oral administra- 
tion of antigen  (10),  repeated immunization with antigen 
(9),  exposure to  superantigens  (8),  and tissue-specific ex- 
pression of antigens  (5,  11).  In addition, a recent report of 
clonal exhaustion has  demonstrated the  selective deletion 
of virus-specific T  cells after challenge with high doses of 
virus (12).  This result adds to a growing body of literature 
that examines the induction of tolerance in the presence of 
high doses of antigen. Several mechanisms have been pos- 
tulated to explain this phenomenon including downregula- 
tion of cell-surface receptors leading to anergy (7,  11) and 
deletion of reactive cells (7, 8, 12). 
The induction of peripheral tolerance via administration 
of high doses of antigen is poorly understood. In vitro data 
investigating the role of high concentrations of antigen on 
the regulation of resting CD4 + T  lymphocytes have dem- 
onstrated a suppression of the proliferative response and in- 
duction of anergy in CD4 + T  cell clones when exposed to 
supraoptimal  antigen  doses  (13).  More  recent  data  from 
Lenardo and  collaborators using TCk  transgenic  animals 
specific for a myelin basic protein (MBP) I peptide, Acl-11, 
demonstrated CD4 + T  cell deletion as a result ofsupraopti- 
mal  peptide/MHC  stimulation  (14).  Transfer  of CD4 + 
cells from the transgenic mice into nontransgenic mice in- 
duced experimental allergic encephalomyelitis in the recip- 
ient  animal.  However,  recipient  mice  treated  with  high 
doses of MBP peptide did not develop experimental aller- 
gic  encephalomyelitis.  In  vitro  studies  showed  that  such 
high antigen conditions resulted in the deletion of recently 
activated  cycling  MBP-reactive  T  cells  via  activation- 
induced cell death (AICD), thereby establishing tolerance. 
AICD  is  thought to  result from reexposure of cycling T 
IAbbreviations used in  this paper: AICD, activation-induced cell death; 
MBP, myelin  basic protein. 
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marily in CD4 + T  cells, AICD has also been observed in 
bulk lymph node CD8 + T  cells stimulated with anti-CD3 
(15), but not in CTL lines of defined epitope specificity. 
Previously, we have demonstrated that CD8 + CTL lines 
of differing avidity can be selected by varying the peptide/ 
MHC determinant density on APC (16).  In this system, se- 
lection of low avidity CTL lines by high determinant den- 
sity should be possible only if high avidi  W CTL are being 
actively deleted. In the current report, we have investigated 
the effect of high dose antigen on CTL of differing avidities 
to define parameters giving rise to negative selection in ma- 
ture, peripheral CD8 + effector T  lymphocytes. Classically, 
the functional consequence of TCR engagement by CD8 + 
CTL has been evaluated by the lysis  of appropriate target 
cells, and under these  circumstances, high dose  inhibition 
has not been observed (17). As little is known about the ef- 
fects of stimulation with supraoptimal antigen on the pro- 
liferative response of either resting or cycling CD8 + CTL, 
CTL  lines of either high  or low  avidity (as  measured by 
their dose response curve to peptide antigen) were exam- 
ined for their proliferative response to  APC pulsed with a 
range of peptide concentrations. The data presented herein 
demonstrate that  CD8 +  CTL can undergo inhibition and 
cell death in a peptide specific and dose titratable manner, 
mediated at least in part by the release of TNF-ot, but not 
by Fas.  In addition, the susceptibility of CTL to inhibition 
at  any  given peptide  concentration is  dependent  on  the 
avidity of those CTL. Importantly, the observed inhibition 
appears to be independent of the initial activation state of 
the CTL, and is set in motion even in resting CTL within 
the first 9 h of stimulation, in contrast to AICD in CD4 + T 
cells.  Thus,  CD8 +  CTL,  depending on their  avidity, are 
susceptible to  negative regulation in the  periphery by su- 
praoptimal peptide/MHC determinant density on APC. 
Materials and Methods 
Mice and Antibodies.  BALB/c mice were purchased from Jack- 
son Laboratories  (Bar Harbor, ME). Anti-CD8ot antibody (clone 
53-6.7), Jo2 anti-fas antibody, and FcBlock were purchased  from 
Pharmingen (San Diego,  CA).  Neutralizing anti-TNF-o~ poly- 
clonal antiserum was purchased from Genzyme (Cambridge,  MA). 
Activity of the anti-Fas antibody to inhibit Fas-Fas ligand interac- 
tion was measured as described  (18; see legend to Fig. 4). 
Peptides.  Peptides  were synthesized on an automated peptide 
synthesizer  (model  430A; Applied Biosystems, Inc., Foster  City, 
CA) using t-boc chemistry  (19). The peptides were cleaved from 
the resin with HF and initially  purified by size exclusion chroma- 
tography (P4 Biogel; Bio-Rad Laboratories, Mountain View, CA). 
Purification to single peaks was achieved by reverse-phase  HPLC 
on Ixbondapack reverse-phase C18  analytical and preparative 
columns (Waters Associates, Milford,  PA). I10 (RGPGRAFVTI) 
is  the  imnmnodominant epitope from gp160  in BALB/c mice 
(20-22). 
Generation  of CTL Lines.  7.5 ￿  1if' responding BALB/c spleen 
cells from mice previously  immunized with a recombinant vac- 
cinia expressing  the  gp16%m  protein from H1V-1  were cocul- 
tured with 3.5 ￿  10  (' stimulating  BALB/c splenocytes (3,000 rad) 
pulsed  with various  concentrations (100, 0.1,  or 0.0001  I~M) of 
I10 peptide or in the presence  of 1 jaM free peptide in a 24-well 
plate containing 2 ml of a 1:1 mixture of RPMI  1640 and Eagle 
Hank's  amino  acid  (EHAA)  medium  supplemented  with 
t-glutamine, sodium pyruvate, nonessential amino acids, penicil- 
lin, streptomycin,  5 ￿  10 -s M [3-mercaptoethanol,  10% FCS, and 
10% T-stim (Collaborative  Biomedical Products,  Bedford,  MA). 
CTL lines were established from primary cultures and were main- 
tained by weekly restimulation of 3-5  ￿  l0  s cells/well in the 
presence  of 5  ￿  lff' irradiated  (3,000  rad) BALB/c spleen  cells 
pulsed with the appropriate  concentration of I 10 peptide. 
r  The S~Cr release assay was  carried  out as 
previously described (23). 10  t' target cells were labeled with 301) ~Ci 
ofNa  2 SlCrO4 in 200-250 p,1 for 2 h at 37~  In some cases, tar- 
gets were pulsed with 10 p,M peptide during labeling. Cells were 
then washed three times and added at 3,000 cells/well  along with 
the appropriate  number ofeffector cells in 96-well round-bottom 
plates. In some cases, peptide was added directly in the CTL assay 
in the absence  of previous pulsing. After  4 h, supernatants  were 
harvested  and  counted in an  Isomedic  gamma  counter  (ICN, 
Horsham, PA). The mean of the triplicate samples was calculated, 
and the percent of SlCr release was calculated  according to  the 
following equation: 
percent  specific 51Cr release =  10() X [(experimental  51Cr release - 
control 51Cr re#ase) / (maximum  5t Cr release -  control s l Cr wlease) ], 
where  experimental SICr release  represents  counts from  target 
cells mixed with effector cells, control 51Cr release represents tar- 
get  cells mixed with medium alone  (spontaneous  release), and 
maxinmm 51Cr release represents counts from target cells exposed 
to 2.5% Triton X-100. 
Proliferation  Assays.  CTL (day 4 [d41 or dl I after stinmlation) 
were plated at 5 ￿  10a/well in a 96-well round bottom microti- 
ter plate.  Where appropriate,  anti-CD8 antibody was added  and 
plates incubated at 37~  for 15 rain. After this incubation, irradi- 
ated  (3,000 rad) BALB/c splenocytes previously pulsed with 110 
peptide and washed three times were added at 3 ￿  10S/well. Su- 
pernatant from the final wash ofstinmlators pulsed with 100 I.zM 
I10 peptide was  reserved  and added  to  wells  with  I).001 ixM- 
pulsed  stinmlators  at a final dilution of 1:1  to ensure that  effects 
seen with 100 b~M-pulsed stimulators was not caused by residual, 
free I10 peptide that could bind the CTL directly.  In some cases, 
Jo2 anti-Fas (10 Ixg/ml) in combination with FcBlock (5 b~g/ml), 
both from  Pharmingen, or anti-TNF-c~ (1:50) antibodies (Gen- 
zyme)  were used.  FcBlock  was added  to prevent possible cross- 
linking of anti-Fas by APC. Proliferation was measured  by addi- 
tion of 1 txCi  [3H]thymidine/well at 0,  24,  or 48  h,  and plates 
were harvested  at 24, 48, or 72 h, respectively.  Results obtained 
at all harvest times were qualitatively sinfilar. Results are the geo- 
metric mean of triplicate cultures. 
Apoptotic Death Assays.  CTL  were  enriched by centrifuging 
lines over Ficoll. After washing,  1  if' CTL were added along with 
5 ￿  10  (' peptide-pulsed stimulators (depleted of Thy 1.2 + cells) in 
2 nfl of medium, containing 10% T-stim as a source  of IL-2, per 
well of a 24-well plate. After 46 b, cells were harvested and incu- 
bated with biotin-conjugated  Thy 1.2 mAb, followed by PE-avi- 
din or FITC-conjugated Thy 1.2 to identify CTL, washed, resus- 
pended in 50%  FCS in PBS,  and penneabilized by addition of 
three parts 70% EtOH. After overnight fixation  at 4~  cells in- 
cubated with Thy  1.2-biotin and PE-avidin were  washed  with 
cold PBS and incubated for 30 nfin with 5 btg/ml Hoechst 33342 
(Molecular  Probes,  Inc., Eugene, OR) at 37~  Cells were then 
centrifuged,  and the pellet was resuspended  in 21) bL1 PBS. Apop- 
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ternatively, EtOH  fixed cells were washed and incubated with 
R.NAse A for 30 rain at 37~  followed by addition ofpropidium 
iodide (25). Cells were analyzed on a FACSort  |  (Becton Dickin- 
son &  Co., Mountain View, CA). The percentage of Thy 1.2 + 
cells with hypodiploid DNA was used as a measure of apoptotic 
death as in (25). 
Results 
CTL Lines with Distinct Avidities Are Differentially Inhibited 
by ,Stimulators  Presenting High Dose Antigen.  CTL  lines were 
generated by stimulation with splenocytes pulsed with  ei- 
ther high dose (100 I~M) or low dose antigen (0.0001  lxM) 
(16). The two lines are distinct in their determinant density 
requirements for both proliferation (Fig. 1 A) and CTL 1y- 
sis, and are stable in  their respective phenotype  (16).  The 
concentration ofpeptide antigen required for optimal pro- 
liferation varied by nearly 1,000-fold between the high and 
low avidity lines (Fig.  1 A).  CTL  were  tested on  d4  after 
routine stimulation and assays were done in the presence of 
10% T-stim as a source of IL-2, as required for proliferation 
by CD8 +  cells in response to antigen.  Fig.  1 A  shows that 
in the presence ofAPC  prepulsed with  100  ~M  I10 pep- 
tide,  the  higher  avidity CTL  (generated  on  0.0001  IxM- 
pulsed stimulators) were completely inhibited in their pro- 
liferative  response.  The  inhibition  was  CD8  dependent, 
since proliferation could be at least partially restored by the 
inclusion ofanti-CD8 antibody (Fig. 1 /3). Further, the res- 
toration was dose dependent in that decreasing amounts of 
anti-CD8  antibody had  a  diminishing ability to  block the 
inhibition. The elegant interplay of CD8 with TCR  recep- 
tor signaling is evident in the contribution by anti-CD8 at 
doses of antigen that are optimal for activation, as measured 
by proliferation  (e.g.,  0.001  I~M),  where  the  presence  of 
anti-CD8 antibody now blocks proliferation by up to 40%. 
Thus,  the contribution of CD8  enhances either inhibition 
or activation of the CTL, depending on the amount of an- 
tigen  present  on  the  stimulator.  In  contrast  to  the  high 
avidity line, the low avidity line is not susceptible to inhibi- 
tion by the same high antigen dose (Fig. 1 A). In fact, con- 
centrations  of peptide  antigen  that  are  inhibitory for  the 
high avidity line promote optimal proliferation of the low 
avidity line.  Furthermore,  proliferation  of this  line  at  all 
peptide doses, even  100  p,M, is susceptible to blocking by 
anti-CD8 antibody (Fig. 1 B). 
To  interpret the  data,  it is important to  determine  that 
the  inhibition  observed  for  the  high  avidity  line  is  not 
caused by residual free peptide in the cells pulsed with high 
dose antigen, which can then bind to and be presented by 
MHC  molecules on the CTL.  Such inhibition by self-pre- 
sentation of peptide has been shown,  in some cases, to re- 
sult in CTL fratricide, suicide, or anergy (26-30).  The in- 
ability of supernatant from the final wash of the  100 or 10 
p~M-pnlsed cells to  cause  inhibition when  added to  wells 
containing 0.001  p~M I10-pulsed stimulators shows that the 
inhibition is  caused solely by presentation  of the  relevant 
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Figure 1.  The d4 high avidity line is inhibited in its proliferative re- 
sponse to APC pulsed with high concentrations ofpeptide, and this inhi- 
bition can be reversed by anti-CD8 antibody. (A) The high and low avid- 
ity CTL  lines were  assayed for  proliferation  on  day  4  after routine 
stimulation. CTL were stimulated with APC pulsed with various concen- 
trations ofpeptide. Cultures were pulsed with [3H]thymidine at 48 h and 
harvested at 72 h. APC pulsed with 100 or 10 p,M peptide inhibited pro- 
liferation of the high avidity line (circle)  while maximally stimulating the 
low avidity line (squares). As a control for residual free peptide, superna- 
tant from the final wash of the 100 and 10 p,M-pulsed APC was added at 
1:1 dilution into wells with 0.001 b~M-pulsed  APC. Counts from addi- 
tion of the 100 I,  tM-pulsed APC wash were 9,174 -+ 270 and from the 
10 ~M-pulsed wash APC were 9,982 +  409, i.e., no inhibition relative 
to wells in the absence of the wash supernatant. (B) The addition of solu- 
ble anti-CD8 antibody partially restored the proliferative response of the 
high avidity line while blocking the response of the low avidity line. An- 
tibody was added at four concentrations: 20 Ixg/ml (solid bars), 5 lig/nfl 
(striped bars), 1.3 ~g/ml (stippled bars), and 0.32 ~g/ml (cross-hatched bars). 
The percentage of shift in response was calculated as 100x  (cpm in the 
presence ofanti-CD8 -  cpm in the absence ofanti-CD8)/cpm in the ab- 
sence of anti-CD8. 
peptide ligand on APC and not to residual free peptide (see 
figure legend). 
To  ensure that the lack of response observed with high 
dose antigen was  not  the  result of very early proliferation 
that was complete by the time of pulsing with  [3H]thymi- 
dine,  a  kinetic  experiment  was  performed.  Inhibition by 
high  dose  antigen  was  observed  even  during  the  0-24-h 
period (data not shown).  This  suggests that  the  inhibition 
observed  was  not  the  result  of a  shift  in  the  kinetics  of 
DNA  synthesis relative to  the  time  of the  pulse,  but  in- 
stead, is a relatively immediate arrest of the proliferative re- 
sponse of the high avidity CTL. 
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Activation of the CTL.  Previous  studies  have  demonstrated 
the importance  of cell cychng for cell death resulting from 
exposure to high  dose antigen  (14)  or high  concentrations 
of anti-TCR  antibody  (31,  32).  Thus,  the  high  and  low 
avidity lines  were  analyzed  for susceptibility  to  high  dose 
inhibition at a time point when they should not be actively 
cycling  (dll  after  routine  stimulation).  As  observed  with 
activated d4 CTL, the high avidity resting CTL were unre- 
sponsive to stimulators pulsed with high dose antigen  (100 
and  10 ~M)  (Fig. 2 A). Furthermore,  the presence ofanti- 
CD8  antibody  could  relieve  the  inhibition  and  allow  for 
antigen-specific  proliferation  (Fig.  2  B).  Again,  in  agree- 
ment with  results  obtained  with  d4  CTL,  the  low avidity 
CTL  line  was  maximally stimulated  by APC  pulsed  with 
high  dose antigen  (100  and  10  p.M),  and  the  proliferation 
was dependent  on  CD8  interaction  at all peptide  concen- 
trations tested  (Fig. 2, A  and B). Thus, we find that CD8 + 
CTL are susceptible to high dose inhibition independent  of 
recent activation and cell cycling. 
High Dose Peptide Antigen  Induces Apoptotic Death  of the 
CTL.  The  observed  inhibition  of the  proliferative  re- 
sponse  to  high  dose  antigen  could  be  the  result  either  of 
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Resting dl 1 high avidity CTL are inhibited in the their pro- 
liferative response to high dose antigen. (A) The high and low avidity 
CTL lines that were dl 1 after routine stimulation were tested as described 
in Fig. 1. Both activated (Fig. 1) and resting high avidity CTL were sus- 
ceptible to high dose inhibition. (B) As with d4 high avidity CTL, anti- 
CD8 antibody allowed response to high dose antigen by dl 1 CTL. Per- 
centage of shift in response was calculated as described in Fig. 1. 
anergy or cell death.  To determine  the  mechanism  of the 
reduction in the proliferative response of high avidity CTL, 
lines  were  stimulated  with  0.001  or  100  I-tM  peptide- 
pulsed  splenocytes  depleted  of Thy  1.2 +  cells.  Depleted 
stimulators were required for discrimination of CTL during 
analysis. 45 h  after stimulation,  cultures were harvested, in- 
cubated  with  biotinylated  anti-Thy  1.2  Ab  followed  by 
PE-avidin  (to  detect  CTL),  and  fixed  overnight.  Samples 
were  then  incubated  with  Hoechst  33342  nuclear  stain. 
When viewed by fluorescence  microscopy,  CTL could be 
distinguished  from  APC  by  red  membrane  staining.  The 
number  of CTL with  apoptotic  nuclei,  known  to  exhibit 
specific  morphological  changes  including  condensation  of 
DNA,  could then be quantitated.  Fig. 3 A  shows that high 
avidity  CTL  stimulated  with  APC  pulsed  with  100  txM 
peptide are undergoing significant apoptosis compared with 
CTL stimulated  with  0.001  IxM-putsed APC  (47  vs. 3%). 
No apoptotic death was observed with the low avidity line 
under  identical  conditions  (Fig.  3  A),  although  both high 
and low avidity lines were susceptible to apoptotic deletion 
using  high  concentrations  of immobilized  anti-CD3  anti- 
body  (data  not  shown).  Results  similar  to  those  observed 
with d4 CTL were obtained with CTL that were 11 d after 
routine stimulation  exposed to APC pulsed with high ver- 
sus low concentrations  of antigen  (data not shown).  Thus, 
regardless  of the  activation  state  of the  CTL,  the  result  of 
exposure to high  dose antigen  is identical  and  occurs with 
the same kinetics.  In addition  to this analysis, CTL under- 
going  apoptotic  death  were  quantitated  by  hypodiploid 
DNA  analysis.  Results  from these  analyses were  in  agree- 
ment with  results obtained  by Hoechst analysis  (Fig.  3  B). 
Apoptotic  death  of the  CTL  line  was  found  to  correlate 
with inhibition  of proliferation. 
When tested for cytolytic activity, high avidity CTL could 
readily lyse target cells pulsed  with  high  concentrations  of 
peptide  (data not shown).  As shown above, however, these 
concentrations ofpeptide cause inhibition and death. These 
two events can be reconciled by examining the kinetics  of 
death. Apoptotic nuclei are not evident at 24 h, but require 
40-48  h  to  appear  (data  not  shown).  Thus,  there  is  ade- 
quate  time for the  earlier  event of cytolysis, which  occurs 
within 4 h  after exposure to antigen-pulsed  targets, to take 
place before the ultimate  death  of the  CTL at a later time 
point. 
Inhibition Can be Prevented by the Presence of Anti-TNF-ce 
Antibody.  Recent evidence suggests that TNF-(x can me- 
diate apoptotic death of CD8 + T  lymphocytes that are un- 
dergoing apoptotic death as a result of hyperengagement of 
the TCR  of recently activated cells via anti-TCR  antibod- 
ies  (15).  To determine  whether  TNF-cl  is involved in  the 
inhibition  observed in  our cultures,  an anti-TNF-cl  poly- 
clonal  antibody  was added  to  CTL  stimulated  with  either 
high  or low  dose  antigen-pulsed  stimulators.  As shown  in 
Fig.  4,  the  presence  of anti-TNF-c~  antibody  restored  the 
proliferative response of high avidity CTL stimulated with 
supraoptimal  peptide/MHC  determinant  density  while 
having no  effect on  the  response  of the  low  avidity  CTL 
line  to  the  same  stimulators.  Fas  cross-linking,  shown  in 
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Figure 3.  The lack of a proliferative response by the high avidity CTL 
to high dose  antigen  is the result  of apoptotic  death.  4  d after  routine 
stimulation,  high and low avidity CTL were analyzed for apoptotic nuclei 
(A) or hypodiploid  DNA (B) 45 h after exposure to high dose or low dose 
antigen. APC (Thy  1.2-depleted  splenocytes) were either unpulsed  (stip- 
pled  bars),  or pulsed with 0.001 ktM (striped  bars),  or 100 p~M (solid  bars) 
peptide.  For analysis ofapoptotic nuclei, CTL were identified by incuba- 
tion with biotinylated-Thy 1.2 and PE-avidin.  Cells were then fixed, and 
Hoechst dye was added to view the nucleus. CTL were assessed for apop- 
totic  nuclear  morphology by fluorescence  microscopy.  As a control for 
residual free peptide,  supematant  from the final wash of the  100 p,M- 
pulsed APC was added at 1:1 in some wells with 0.001 p.M-pulsed  APC 
and 14% of CTL contained  apoptotic nuclei. For hypodiploid  DNA anal- 
ysis, CTL were identified by incubation  with FITC-conjugated antibody 
specific for Thy t.2. Propidium  iodide was added for DNA detection. 
multiple  studies  to  induce  death  of T  lymphocytes,  does 
not appear to be involved in the inhibition and death under 
the  conditions  tested  here,  since  soluble  anti-Fas  antibody 
did not restore the proliferative response of the high avidity 
CTL  (Fig. 4). 
Discussion 
This  study  reports  the  ability of high  dose  peptide  anti- 
gen presented by APC  to induce apoptotic  death in a  high 
avidity CD8 §  CTL line while maximally activating CTL of 
lower avidity. This is the first report to document a role for 
increasing peptide ligand presented by APC  in the deletion 
of mature  CD8 §  CTL, as well as the contribution  of avid- 
ity in determining cell fate. These findings are distinct from 
previous  studies  of CD8 §  CTL  in which  the  effect of su- 
praoptimal  TCR  stimulation  via  antibody  or  purified  al- 
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Neutralizing  anti-TNF-a  antibody  can reverse the inhibi-  Figure 4. 
tion obtained  with supraoptimal peptide/MHC determinant  density. 4 d 
after routine stimulation,  high (A) and low (B) avidity CTL were assayed 
for proliferation  resulting  from stimulation  with  irradiated  splenocytes 
pulsed with various concentrations  ofpeptide antigen, as described in Fig. 
1 A. No antibody  (stippled  bars),  neutralizing  anti-TNF-er antibody,  1:50 
(solid  bars),  or Jo2  anti-Fas  antibody  (10  Ixg/ml;  cross-hatched  bars)  was 
added to determine  the role of these two molecules in the inhibition  ob- 
served. In the case of the anti-Fas antibody,  FcBlock (5 p~g/ml) was added 
to prevent possible cross-linking  of the antibody  by APC. (In other ex- 
periments,  the presence of FcBlock alone did not affect the response.) No 
significant effect was observed in the presence  of anti-Fas antibody.  As a 
positive  control for the function of the anti-Fas antibody,  we tested its 
ability to  inhibit  lysis of Fas-expressing L1210  transfectants by the  Fas 
ligand-expressing  d11S CTL hybridoma  (18). At a 15:1 E/T ratio,  the 
anti-Fas antibody  (10  p,g/ml)  inhibited specific SlCr release from 78  + 
2% in the absence of antibody to 15 +  2%, in the presence of the antibody 
(81% inhibition). 
loantigen  was  not  assessed  either with  regard  to  the  inde- 
pendent  role  of increasing  peptide  ligand  density  or  with 
regard to the effects of such treatment  on resting CTL  (31, 
33).  The data presented in this study suggest that the num- 
ber  of peptide  determinants  presented  by  the  APC  regu- 
lates  either  positively  or  negatively  the  ability  of CTL  to 
proliferate in response  to antigen.  High avidity CTL, capa- 
ble  of being  activated  by  a  low number  of peptide/MHC 
complexes,  are  deleted  by  exposure  to  APC  with  a  very 
high density of peptide/MHC  complexes, while low avid- 
ity CTL  are maximally stimulated  at this same  high deter- 
minant density. 
The ability of soluble anti-CD8 Ab to restore the prolif- 
erative  response  of high  avidity  CTL  stimulated  with  100 p~M-pulsed APC suggests that the signal received by CTL 
is a summation of the interaction of a number of proteins, 
in  this  case,  the  TCR  and  CD8.  If the  combined  signals 
from these  two  receptors  reach  a  certain  threshold,  then 
cells are activated. If, however, the signal surpasses  a higher 
threshold,  above the range for activation, as is the case for 
high  avidity  CTL stimulated  with  APC  pulsed with  100 
~M peptide, death will result, due at least in part to the re- 
lease  of TNF-oc  However, if the  contribution  of CD8  is 
blocked, then the lower level of signal generated results in 
CTL proliferation.  In situations  in  which  the  number  of 
peptide/MHC complexes is more limited, the level of sig- 
nal  delivered  from TCR  binding  alone  is  insufficient  to 
reach the threshold required for activation, and signal am- 
plification via CD8 becomes a mandatory part of the inter- 
action to stimulate proliferation.  Thus,  the engagement of 
CD8  and  TCR  is  critical  both  for positive  and  negative 
regulation of CTL. 
At first,  the observed inhibition of the d4 CTL seems to 
be similar to the activation-induced death reported by oth- 
ers  (14,  15, 31, 32, 34-38).  It is thought that death via this 
pathway depends  on  the  reexposure of recently activated 
cycling cells  to  one of a variety of stimuli  (8,  14,  31,  32, 
34-38).  The inhibition  of CD4 + cell proliferation at high 
antigen  concentration  may be the  result  of a  second  en- 
counter of the cells with antigen within 24 h  of the initial 
stimulation, resulting in AICD (1,  14). 
The data presented here suggest that both resting and ac- 
tivated CD8 + CTL are equally susceptible to inhibition and 
apoptotic death by high concentrations  of peptide antigen 
presented  by  MHC  on  the  surface  of APC.  Similar  to 
AICD,  we  observe apoptotic  deletion  in  response to  su- 
praoptimal peptide/MHC  determinant density. Before the 
present report, this had not been reported for peptide-spe- 
cific,  CD8 + CTL.  In addition, we have demonstrated that 
the mediator of death is, at least in part, TNF-cx, in agree- 
ment with a recent study by Zheng et al. in which hetero- 
geneous populations of CD8 + lymph node T  lymphocytes 
were stimulated with high doses of anti-CD3  antibody to 
induce AICD (15).  In our study, the apoptotic death of the 
high  avidity  CTL  line  suggests  that  TNF-cx  is  produced 
only after stimulation with very high peptide/MHC deter- 
minant density or that high determinant density is required 
to achieve levels of TNF-~ production that are capable of 
inducing apoptotic death. Alternatively, the action of TNF-~x 
may be attributable to differential TNF-cx receptor regula- 
tion after stimulation with various antigen doses. Identifica- 
tion  of TNF-cx as  the  mediator of the  apoptotic signal is 
likely to be the explanation for the requirement of 40-48 h 
before apoptotic death is measurable after stimulation with 
high concentrations of pulsed peptide antigen. Experiments 
are currently underway to determine whether this process 
is regulated by increased TNF-cx production or TNF-oL re- 
ceptor upregulation or both. 
Although  the  above similarities  exist,  several important 
differences  from  AICD  are  apparent.  First,  Fas  and  Fas 
ligand,  which  have  been  suggested  to  mediate  classical 
AICD  (39),  do not play a role here  (Fig.  4).  Second,  our 
data demonstrate that high avidity, activated d4 CTL, and 
resting  dll  CTL  require  40-48  h  for the  appearance  of 
apoptotic nuclei.  As discussed  above, for AICD to  occur, 
resting CD4 + cells are thought to require two distinct acti- 
vation  encounters  with  antigen,  and  it  is  the  second  en- 
gagement by the  now  cycling cell  that  is  responsible  for 
triggering death.  Experiments with  dl 1 CTL used in  this 
study, in which  100  btM-pulsed APC were removed after 
9 h of exposure and the CTL were replated in the presence 
of unpulsed  APC,  demonstrated  that  the  commitment  to 
death has already occurred during this initial antigenic en- 
counter, suggesting that these CTL do not require a second 
encounter with antigen  while  cycling to induce  apoptosis 
(data  not  shown).  The  only precedent  for inhibition  and 
apoptosis resulting from a single encounter with antigen is 
in  the  nonphysiological  case  of T  cell  hybridomas  (40). 
Moreover,  the  same  concentration  of peptide  is  required 
for the  deletion of both recently activated and resting CTL 
(Figs. 1 A and 2 A). Thus, there is no evidence that actively 
cycling CD8 + CTL ceils are more predisposed or sensitive 
to supraoptimal TCR  engagement for induction  of apop- 
totic death. Finally, as noted previously, proliferation of the 
CTL in response to high dose antigen is inhibited from the 
very beginning  of the  culture,  as  determined  by  a  pulse 
with  [3H]thymidine between 0-24 h  after initiation of the 
culture.  Together,  these  data  support  the  hypothesis  that 
the signal resulting in apoptosis of resting CTL is a result of 
the  first antigenic  stimulation  with  supraoptimal detemai- 
nant density. These data argue that the strength of signal is 
much  more  important  in  determining  the  outcome  of 
TC1L engagement by CD8 + CTL effector lines than is the 
activation state  of the  ceils  prior to  encounter  with  pep- 
tide/MHC. 
Several studies have shown that CTL-CTL presentation 
ofpeptide can cause inhibition oflytic function, anergy, or 
death  (26-30).  However  results  obtained  using  T  cell- 
depleted APC or addition  of control supernatant from the 
final wash of 100  I~M-pulsed APC rule out the possibility 
ofT cell-T cell antigen presentation or free peptide inhibi- 
tion in our system. 
The  data  presented  herein  may help  explain  results  by 
Moskophidis et al., which suggest that CTL capable of viral 
clearance undergo deletion as a result of clonal exhaustion 
after challenge with large doses of virus  (12).  Under such 
circumstances,  viral  antigen  may  be  either  constitutively 
presented for extended periods of time or presented at an 
increased level at the cell surface on a per cell basis. Our re- 
suits  suggest that the  latter would result in the deletion  of 
high avidity CTL, which are more effective for viral clear- 
ance,  leaving only low avidity CTL inadequate  to control 
viral spread (16,  41).  Moreover,  it has been demonstrated 
that during the course of HIV-1 infection,  there is an on- 
going loss  of HIV-specific CD8 + T  cells  (42).  Given the 
viral  load  attained  during  HIV-1  infection,  it  is  possible 
that a determinant density is achieved which is capable of 
inducing  deletion  of the  virus-specific cells,  in  a  manner 
analogous to the deletion reported in this study. 
Our previous finding (16) that only low avidity CTL are 
490  High Dose Inhibition and Apoptosis of CD8 + Cytotoxic T Lymphocytes expanded  under  conditions  of high  dose  antigen  are  ex- 
plained by the data presented here. Under such conditions, 
high avidity cells would undergo apoptosis as a result ofsu- 
praoptimal  engagement  of the  TCR,  and  thus  be  deleted 
from the line. 
In  conclusion,  the  delivery  of an  activating  signal  to 
CTL is complex and several proteins are likely to contrib- 
ute.  Preeminent among these are the TCR  and CD8.  The 
number of peptide/MHC  complexes required  for optimal 
TCR  engagement  is  a  function  of the  inherent  require- 
ments of the CTL in that there is a specific range of deter- 
minant  densities  that is  acceptable  for activation and con- 
centrations  of ligand  that  exceed  this  range  will  induce 
deletion of the  CTL, mediated at least in part by the pro- 
duction of TNF-c~, and not by Fas-FasL interaction. In ad- 
dition,  susceptibility to high dose inhibition by the CTL is 
not restricted  to recently  activated  cells.  The  deletion  re- 
ported here may contribute to high zone tolerance and/or 
clonal exhaustion, and loss ofHIV-specific CTL during pro- 
gression  toward  AIDS.  Moreover,  this  knowledge  may 
have implications for therapy ofautoimmune diseases or al- 
lograft rejection. 
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